RhythmAnalytics vs SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

RhythmAnalytics

by Biofourmis Singapore Pte.

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

AI Verdict

RhythmAnalytics specializes in the automated interpretation of cardiac arrhythmias from single-lead ECG data, offering insights into the heart's electrical activity. SENSICARDIAC MOBI, conversely, focuses on assisting physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope. While both are FDA-cleared AI-powered clinical decision support tools within cardiology, they address distinct diagnostic areas using different types of cardiac data.

Choose RhythmAnalytics if…

Choose RhythmAnalytics if your primary need is automated, AI-powered interpretation of cardiac arrhythmias from single-lead ECG data. This tool is ideal for healthcare providers and integrators looking to enhance clinical decision support by detecting a wide range of arrhythmias from various FDA-cleared ECG devices, including Holter monitors and wearable sensors. Its cloud-based API facilitates seamless integration into existing workflows for continuous or intermittent cardiac rhythm monitoring.

View RhythmAnalytics →

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SENSICARDIAC MOBI if you require an AI-powered mobile application to assist in the diagnosis of heart murmurs during a physical examination. This tool is best suited for physicians who need support in differentiating between physiological and pathological heart sounds by analyzing acoustic signals from an electronic stethoscope at the point of care. It provides immediate decision support to complement a physician's assessment of suspected murmurs.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	RhythmAnalytics	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Pricing	Contact vendor	Contact for pricing
Deployment	Cloud-based API	Hosted server environment (Linux OS) with a mobile application interface
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Tool B, SENSICARDIAC MOBI, is a mobile application with a user interface that has undergone testing and shown improvement over predicate devices, scoring positively in user evaluations. While Tool A, RhythmAnalytics, also passed general usability tests, its cloud-based API deployment means the ultimate end-user experience is dependent on the integrating system, whereas Tool B offers a more direct, tested clinical user interface.

Clinical Value

RhythmAnalytics

Both tools are FDA-cleared and offer significant clinical decision support in cardiology. However, RhythmAnalytics (Tool A) demonstrates strong published performance metrics, including high sensitivity (90.8%) and specificity (98.2%) for arrhythmia detection, outperforming a panel of cardiologists and other deep learning systems. It was trained on over 4 million ECG recordings, indicating a robust validation dataset.

Pricing & Value

Tie

Neither RhythmAnalytics (Tool A) nor SENSICARDIAC MOBI (Tool B) provide publicly available pricing information, both stating 'contact vendor' or 'contact for pricing'. Without transparent pricing, it is impossible to conduct a head-to-head comparison of their value propositions.

Enterprise Readiness

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Both tools are FDA-cleared and HIPAA compliant, which are crucial for enterprise readiness. However, SENSICARDIAC MOBI (Tool B) explicitly states it 'has_baa': 'yes' in its specifications. RhythmAnalytics (Tool A) lists its BAA status as 'unspecified', which represents a significant gap for healthcare enterprises requiring clear Business Associate Agreements for PHI handling.

Innovation

RhythmAnalytics

Both tools leverage AI for innovative cardiac diagnostics. RhythmAnalytics (Tool A) utilizes enhanced deep learning architecture trained on millions of ECG recordings to detect over 15 (and up to 30+) types of cardiac arrhythmias, offering broad integration capabilities with various FDA-cleared ECG devices. This extensive scope and sophisticated AI architecture for ECG analysis give it a slight edge in innovation.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer comprehensive or comparable information regarding dedicated customer support channels, service level agreements, or extensive public documentation for either RhythmAnalytics (Tool A) or SENSICARDIAC MOBI (Tool B). While some general mentions of 'instructions for use' or 'support staff' exist, there's insufficient detail for a definitive comparison.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	RhythmAnalytics	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Name	RhythmAnalytics	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Company	Biofourmis Singapore Pte.	DIACOUSTIC MEDICAL DEVICES (PTY)
Primary Function/Focus	AI-powered automated interpretation of cardiac arrhythmias from single-lead ECG data	AI-powered mobile application assisting physicians in diagnosing heart murmurs by analyzing acoustic heart signals
Data Input	Single-lead ECG data	Acoustic heart signals from an electronic stethoscope
Detected Conditions	Over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats)	Distinguishes between normal/physiological and pathological heart murmurs; identifies S1, S2, and suspected murmurs
Specialties	Cardiology, Emergency Medicine, Internal Medicine	Cardiology, Internal Medicine, Pediatrics

Videos

Demos, reviews, and walkthroughs featuring RhythmAnalytics and SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do RhythmAnalytics and SensiCardiac Mobi integrate into a physician's existing clinical workflow and what is the typical depth of EHR integration for each?

RhythmAnalytics offers a cloud-based API for integration, allowing it to connect with existing cardiac monitoring solutions and potentially integrate deeply with EHRs to streamline the flow of ECG data and interpretations. SensiCardiac Mobi operates as a mobile application that acquires and records acoustic heart signals using a compatible electronic stethoscope, fitting into a physical exam workflow with data capture and display on the app. Its integration with EHRs would likely involve exporting detailed cardiac reports, which are presented as downloadable PDFs.

For which specific clinical scenarios or patient populations would RhythmAnalytics be most beneficial compared to SensiCardiac Mobi?

RhythmAnalytics is best suited for managing patients with suspected or known cardiac arrhythmias, providing automated interpretation from single-lead ECG data for specialties like cardiology, emergency medicine, and internal medicine. SensiCardiac Mobi is designed to assist in the diagnosis and differentiation of heart murmurs during auscultation, making it particularly valuable in cardiology, internal medicine, and pediatrics for screening and initial assessment.

What specific performance metrics are available for the AI algorithms in detecting arrhythmias (RhythmAnalytics) or differentiating murmurs (SensiCardiac Mobi), and how were these validated?

RhythmAnalytics has demonstrated high accuracy in detecting over 15 types of cardiac arrhythmias, with reported sensitivity of 90.8% and specificity of 98.2% in validation studies, outperforming a panel of cardiologists. SensiCardiac Mobi's Sensi Diagnostic Heart Murmur Algorithm distinguishes between normal/physiological and pathological heart murmurs, with studies on similar AI-based murmur detection algorithms showing sensitivities around 85.6-93% and specificities around 81-97%. Both tools are FDA-cleared, indicating their algorithms have undergone rigorous validation processes to demonstrate their accuracy and reliability for their intended use.

What is the expected learning curve for physicians and clinical staff to effectively utilize each tool, and what training resources are provided?

RhythmAnalytics, being an API-driven solution, may have a learning curve primarily for IT integration and for physicians to become proficient in interpreting its automated ECG analysis results. SensiCardiac Mobi, as a mobile application with guided auscultation, is likely intuitive for physicians already familiar with electronic stethoscopes, with training focusing on optimal data acquisition and interpretation of the app's output. Usability validation for SensiCardiac Mobi showed that users scored its usability highly, suggesting a relatively low learning curve.

Beyond standard compliance, what specific security measures are in place to protect patient data, and what audit-trail features are available for tracking AI interpretations and physician interactions?

While both tools are HIPAA compliant, specific details beyond this regarding advanced security measures like data encryption, access controls, and comprehensive audit-trail functionalities for tracking AI interpretations and physician actions are not explicitly detailed in the provided information. These features are crucial for maintaining data integrity and accountability within a clinical setting, and further inquiry with each vendor would be necessary to understand their specific implementations.

What are the key considerations for implementing RhythmAnalytics or SensiCardiac Mobi across multiple clinical sites or a large healthcare system?

For RhythmAnalytics, multi-site implementation would primarily involve integrating its cloud-based API with the various ECG data sources and EHRs across different locations, leveraging its scalability for ECG analysis. SensiCardiac Mobi, being a mobile application, would require managing device provisioning, user access, and ensuring compatible electronic stethoscopes are available and maintained at each site, with its hosted server environment supporting centralized management.